Jiménez Romero, M.E.; Díez Farto, S.; Navarro Serrato, J.C.; Canelón Castillo, E.; Revelo Cadena, I.
(Experimental Oncology, 2018)
Objective: Over the last decade, significant advances have been made in the development of therapies for patients with metastatic castration-resistant prostate cancer. Abiraterone and enzalutamide were approved as treatments ...